Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-036268

President, CEO, and Chairman gave up 106,093 shares (to pay taxes)

  • President, CEO, and Chairman acquired 572,983 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sommadossi Jean-Pierre President, CEO, and Chairman 2026-01-31 Option exercise +272,983 573,923 D: show line 1 in the form
Sommadossi Jean-Pierre President, CEO, and Chairman 2026-01-31 Shares withheld for taxes −106,093 $4.24 $449,834 467,830 D: show line 2 in the form
Sommadossi Jean-Pierre President, CEO, and Chairman 2026-02-03 Option exercise +300,000 $1.24 $372,000 767,830 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sommadossi Jean-Pierre President, CEO, and Chairman 2026-01-31 Option exercise · Restricted Stock Units −173,466 0 D: show line 4 in the form
Sommadossi Jean-Pierre President, CEO, and Chairman 2026-01-31 Option exercise · Restricted Stock Units −99,517 0 D: show line 5 in the form
Sommadossi Jean-Pierre President, CEO, and Chairman 2026-02-03 Option exercise · Stock Option (Right to Buy) −300,000 0 D: show line 6 in the form
Loading xslF345X05/ownership.xml…